State HPV Legislation: Issues and Successes

Learning Objectives for this Presentation:
By the end of the presentation, participants will be able to:
1. Discuss an overview of state legislation and the HPV vaccine.
2. Identify States that have passed HPV legislation.
3. Discuss the impact of HPV on school vaccination requirements.

Background:
In 2006, the Advisory Committee on Immunization Practices recommended immunizing adolescent girls between 11-12 ears of age against the Human Papillomavirus (HPV), which is linked to 70% of cervical cancer cases and 90% of cases of genital warts. The vaccine is available through the federal Vaccines for Children program in all 50 states, Chicago, New York, Philadelphia, Washington DC and San Antonio. Legislation has been introduced in 41 states and passed in 17 states to require, fund or educate the public about the HPV vaccine. Separate legislation has been introduced in 24 states and passed in 1 state that would specifically mandate HPV vaccine for school entry.

Setting:
Educational settings

Population:
Partners and Immunization Programs interested in impact of state legislation, specifically school laws on the implementation of newly recommended adolescent vaccines.

Project Description:
A panel of speakers representing national and state organizations will outline the differences between legislative approaches surrounding HPV vaccine. Participants will become aware of current state laws and introduced legislation regarding HPV vaccine in their state, and gain insight into unintended consequences of requiring HPV vaccine for school.

Results/Lessons Learned:
Participants will learn about HPV-specific state legislation. The state legislative analysis will be useful for programs implementing this relatively new vaccine into their program.